MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN)

CUSIP: 62855J104

Q3 2013 13F Holders as of 30 Sep 2013

Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
93,057,750
Total 13F shares
4,180,286
Share change
+832,095
Total reported value
$98,234,919
Price per share
$23.50
Number of holders
14
Value change
+$19,553,600
Number of buys
8
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 62855J104?
CUSIP 62855J104 identifies MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q3 2013

As of 30 Sep 2013, MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,180,286 shares. The largest 10 holders included SYSTEMATIC FINANCIAL MANAGEMENT LP, PDT Partners, LLC, WELLS FARGO & COMPANY/MN, Citadel Advisors LLC, HUNTINGTON ASSET ADVISORS, INC., Partner Fund Management, L.P., Northwest & Ethical Investments L.P., Zurcher Kantonalbank (Zurich Cantonalbank), BANK OF MONTREAL /CAN/, and PineBridge Investments, L.P.. This page lists 14 institutional shareholders reporting positions in this security for the Q3 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.